Ropes & Gray represented Viridian Therapeutics, Inc. in the offering, and Wilmer Cutler Pickering Hale and Dorr represented the underwriters. Viridian Therapeutics, Inc. (Nasdaq: VRDN), a...
Viridian Therapeutics’ $258.8 Million Follow-on Public Offering
Viridian Therapeutics’ Follow-On Public Offering
Troutman Pepper advised Viridian Therapeutics on the deal. Viridian Therapeutics, In announced that it had issued shares in an underwritten public offering resulting in Viridian receiving approximately...